Clene Inc. is a clinical-stage pharmaceutical company developing clean-surfaced nanotechnology (CSN) therapeutics for neurodegenerative diseases. Its lead asset, CNM-Au8, is a catalytically-active gold nanocrystal suspension targeting ALS, MS, and Parkinson's disease by improving NAD+ production and mitochondrial function. The company also develops antiviral/antibacterial agents (CNM-ZnAg, CNM-AgZn17) and dietary supplements through subsidiary dOrbital and licensee 4Life Research.
expected 2026-12-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-17 | 2025-12-31 | 0001437749-26-008502 | EDGAR | 109K words |
| 2025-03-24 | 2024-12-31 | 0001437749-25-008956 | EDGAR | 108K words |
| 2024-03-13 | 2023-12-31 | 0001437749-24-007542 | EDGAR | 101K words |
| 2023-03-13 | 2022-12-31 | 0001437749-23-006264 | EDGAR | 107K words |
| 2022-03-11 | 2021-12-31 | 0000950170-22-003410 | EDGAR | 101K words |
| 2021-03-29 | 2020-12-31 | 0001213900-21-018061 | EDGAR | 102K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-04 | 2026-09-30 | 0001437749-26-034776 | EDGAR | 37K words |
| 2026-08-14 | 2026-06-30 | 0001437749-26-027828 | EDGAR | 37K words |
| 2025-11-13 | 2025-09-30 | 0001437749-25-034613 | EDGAR | 39K words |
| 2025-08-14 | 2025-06-30 | 0001437749-25-026679 | EDGAR | 36K words |
| 2025-05-07 | 2025-03-31 | 0001437749-25-014918 | EDGAR | 34K words |
| 2024-11-13 | 2024-09-30 | 0001437749-24-034663 | EDGAR | 35K words |
| 2024-08-07 | 2024-06-30 | 0001437749-24-025014 | EDGAR | 34K words |
| 2024-05-08 | 2024-03-31 | 0001437749-24-015209 | EDGAR | 30K words |
| 2023-11-07 | 2023-09-30 | 0001437749-23-030487 | EDGAR | 41K words |
| 2023-08-14 | 2023-06-30 | 0001437749-23-023409 | EDGAR | 40K words |
| 2023-05-12 | 2023-03-31 | 0001437749-23-014242 | EDGAR | 32K words |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022333 | EDGAR | 38K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-04 | 0001437749-26-034775 | EDGAR | 3K words |
| 2026-10-20 | 0001437749-26-032960 | EDGAR | 1K words |
| 2026-10-19 | 0001437749-26-032882 | EDGAR | 1K words |
| 2026-09-16 | 0001437749-26-030581 | EDGAR | 17K words |
| 2026-08-14 | 0001437749-26-027837 | EDGAR | 3K words |
| 2026-08-10 | 0001437749-26-026653 | EDGAR | 3K words |
| 2026-03-17 | 0001437749-26-008482 | EDGAR | 4K words |
| 2026-03-12 | 0001437749-26-007828 | EDGAR | 3K words |
| 2026-02-24 | 0001437749-26-005156 | EDGAR | 1K words |
| 2026-01-13 | 0001437749-26-001196 | EDGAR | 23K words |
184 total filings indexed. 156 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001822791 |
| Ticker | CLNN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.clene.com |
| Listed | 2020-12-31 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CLNN (~200 tokens, structured JSON with cryptographic provenance)